Transfer Technology International Corp.'s Organic Citrus Canker Control Formula Indicates 100% Eradication

TAMPA, FL--(Marketwire - April 23, 2009) - Transfer Technology International (PINKSHEETS: TTIN), an emerging technology transfer company, announced today additional laboratory test results for its organic citrus canker control formulation.

In the second round of independent lab testing, Transfer Technology International’s organic canker control formula continued to indicate a 100% eradication of bacteria that causes citrus canker. The second tests also concluded that 24 hours after application, the organic canker control formula allowed no bacterial growth or survival. APL Sciences, Inc. concluded that, based on the numerical populations, each antimicrobial treatment appears to be effective for a 100% reduction of the bacteria after 1 minute of contact. When the bacteria were subjected to constant contact with the antimicrobial agent for up to 24 hours, there was consistently no recovery of the bacteria after 1 minute. For direct contact, the antimicrobial agent accomplished its maximum bacteria inactivation within 5 minutes.

Chris Trina, Chairman and CEO, states, “Our formula continues to perform at the highest levels in laboratory testing. 100% eradication of the canker organisms will change the world for our farmers. We believe our non-toxic, environment friendly, biodegradable formula will be the best and only logical choice for agriculture use in the fight against citrus canker. While more testing is ahead of us before we get to the marketplace, I am confident we have a real winner in this product. It will be more effective, more eco-friendly, and more responsible than current canker suppression products.”

About Transfer Technology International Corp. (PINKSHEETS: TTIN)

Our company was formed to support research, development, and commercialization of cutting edge, socially responsible technologies. Product commercialization, technology transfer, and market penetration will provide the basis for superior financial returns.

Please visit our website, www.ttinternationalcorp.com, for more information.

Disclaimer and Forward-Looking Statements -- The information contained herein regarding risks and uncertainties, which may differ materially from those set forth in these statements, in addition to the economic, competitive, governmental, technological and other factors, constitutes a “forward-looking statement” within the meaning of Section 27A of The Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and is subject to the safe harbors created thereby. While the company believes that the assumptions underlying such forward-looking information are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking information will prove to be accurate. Accordingly, there may be differences between the actual results and the predicted results, and actual results may be materially higher or lower than those indicated in the forward-looking information contained herein.


Contact:
Mr. Christoph Trina
Chairman and CEO
(813) 600-4081

Scientific Data inquiries:
LeeAnn Applewhite
(352) 376-9762